Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00425178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Oct 31, 2019, no change to tracked fieldsv7-v8
  2. Primary completion date: Sep 2, 2006 Completion date: Dec 1, 2006 · Start date: Sep 2005 to Sep 2, 2005 · Collaborators expanded, about 3 wordsv6 Show 3 more changesShow less
    • Completion date: Dec 1, 2006
    • Start date: Sep 2005 to Sep 2, 2005
    • Collaborators expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Eligibility criteria revisedv5 See this version in full on ClinicalTrials.gov ↗
  4. Trial status: Recruiting to Completed Site details revisedv4 Show 1 more changeShow less
    • Site details revised
  5. Study sites: 2 to 1v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.
Trial Details
NCT Number NCT00425178
Lead Sponsor Venturis Therapeutics, Inc.
Collaborators: Warren General Hospital
Conditions Chronic Wounds, Diabetes, Venous Stasis Ulcers
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov